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E2 is an important determinant of Sindbis virus neurovirulence. Increased heparan sulfate (HS) binding is associated with rapid clearance of
viremia and usually with decreased virulence. However, substitution of histidine for arginine at E2-157 (R157H) or glutamate for lysine at E2-159
(K159E) produces viruses with decreases in heparin-Sepharose binding and increases in viremia but different levels of binding to HS-expressing
cells and virulence phenotypes in newborn CD-1 mice (Byrnes, A.P., Griffin, D.E., 2000. Large-plaque mutants of Sindbis virus show reduced
binding to heparan sulfate, heightened viremia and slower clearance from the circulation. J. Virol. 74, 644–651). To identify mechanisms of
virulence, R157H and K159E were studied in newborn CD-1 and BALB/c mice. Subcutaneous inoculation of R157H caused 100% and K159E
60% mortality in 2-day-old CD-1 mice. R157H caused 25% and K159E no mortality in 2-day-old BALB/c mice. R157H and K159E replicated
similarly at the site of inoculation with the same level of viremia, but clearance was slower in CD-1 than BALB/c mice. R157H replicated better
than K159E in the central nervous system (CNS) after subcutaneous and intracerebral inoculation and in undifferentiated neurons. These studies
show a genetic restriction of replication in newborn BALB/c mice, and that amino acid substitutions affecting binding to proteoglycans may differ
in importance for CNS infection and viremia.
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Sindbis virus (SINV) is an enveloped, message-sense RNA
virus in the Togaviridae family and the prototypical member of
the Alphavirus genus. SINV is transmitted by mosquitoes
primarily to birds but can cause fever, arthritis, and skin rash in
humans (Johnson et al., 1972; Malherbe et al., 1963). In mice,
SINV causes encephalomyelitis and is a model system for
understanding determinants of virulence for the encephalitic
alphaviruses, such as eastern, western, and Venezuelan equine
encephalitis viruses. In the central nervous system (CNS),
SINV targets neurons (Jackson et al., 1987, 1988). Depending0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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causes encephalitis, paralysis, or no observable disease
(Griffin, 1976; Johnson et al., 1972; Thach et al., 2000; Tucker
et al., 1996). Understanding the viral and host determinants of
neurovirulence is essential for eventually understanding the
pathogenesis of alphavirus encephalitis.
Alphaviruses have two glycoproteins, E1 and E2, inserted
into the viral lipid membrane. E2 functions for attachment and
E1 for fusion of the virus membrane with the cell membrane.
E1 and E2 form heterodimers that trimerize to produce
80 spikes on the surface of the virion (Strauss and Strauss,
1994). After E2-mediated attachment of the virus, SINV is
endocytosed via clathrin-coated vesicles, and a conformational
change in the E1-E2 dimer, induced by the low pH of the
endosome, allows E1 to bind and fuse with the cell membrane
and release the viral nucleocapsid into the cytoplasm (Helenius
et al., 1980, 1982; Strauss and Strauss, 1994). The amino acid
sequence of the E2 glycoprotein is an important determinant6) 183 – 190
www.e
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1997), but mechanisms by which these changes affect
induction of neurological disease are less clear.
The broad host range of SINV suggests that the E2
glycoprotein can recognize a wide repertoire of cellular
receptors or a cellular receptor that is highly conserved across
multiple species including humans, mice, birds, and mosqui-
toes. Evidence suggests that SINV employs multiple cellular
receptors including highly conserved cellular molecules, and
that different strains of SINV preferentially utilize different
receptors (Smith and Tignor, 1980; Ubol and Griffin, 1991;
Wang and Strauss, 1991; Wang et al., 1992). Many viruses,
including arthropod-borne viruses, are selected for binding to
the glycosaminoglycan heparan sulfate (HS) during passage in
cell culture (Bernard et al., 2000; Byrnes and Griffin, 1998;
Germi et al., 2002; Heil et al., 2001; Klimstra et al., 1998; Su
et al., 2001), and many strains of SINV bind HS efficiently.
Cryoelectron microscopy shows the alphavirus HS-binding site
on E2 at the distal end of the glycoprotein spike, a region
implicated in cell attachment (Zhang et al., 2005). Increased
binding of alphaviruses to HS usually results in small plaque
size under agar, more rapid clearance from the blood, and
reduced virulence for mice (Bernard et al., 2000; Byrnes and
Griffin, 2000; Klimstra et al., 1998).
In a previous study, we identified changes in amino acid
residues of E2 that are selected in mice with prolonged SINV-
induced viremia and found that these changes affect HS
binding (Byrnes and Griffin, 2000). In essentially all instances,
decreased efficiency of binding to heparin was associated with
replacement of a positively charged amino acid in E2 with an
uncharged or acidic amino acid. A panel of recombinant
viruses was then constructed with single amino acid changes
that altered the binding of SINV strain Toto 1101 to heparin.
For all the recombinant viruses, decreased heparin binding was
associated with increased plaque size under agar and decreased
virus clearance from the blood. These viruses also produced a
higher level of viremia after subcutaneous inoculation in
newborn CD-1 mice than Toto1101, and this usually, but notFig. 1. Survival of newborn CD-1 and BALB/c mice after subcutaneous inoculation
subcutaneously in the right hind foot with 1000 pfu of R157H or K159E (10–16 mic
R157H was more virulent than K159E in both strains of mice (CD-1, P = 0.0083,always, resulted in increased mortality (Byrnes and Griffin,
2000).
To better understand how viremia and HS binding relate to
neuroinvasion and neurovirulence, we have studied the
pathogenesis of a pair of recombinant viruses with similar
heparin-binding properties and levels of viremia, but different
virulence properties in newborn mice. Viruses with substitution
of histidine for arginine at E2 residue 157 (R157H) or
substitution of glutamate for lysine at nearby E2 residue
159 (K159E) produce levels of viremia that are similarly
increased over that of the Toto 1101 parent strain. However,
R157H has increased virulence in neonatal mice, while the
mortality due to K159E is not increased and is similar to that of
Toto 1101 (Byrnes and Griffin, 2000). To identify the reasons
for these differences in virulence, we have further studied the
pathogenesis of these 2 recombinant viruses and determined
that R157H and K159E differ in their ability to replicate in the
CNS, and that this is independent of their ability to replicate in
the periphery and cause viremia. Comparison of newborn CD-1
mice with BALB/c mice demonstrated relative resistance of
newborn BALB/c mice to fatal disease.
Results
Mortality after subcutaneous inoculation in CD-1 and
BALB/c mice
Previous studies of recombinant viruses on a Toto 1101
background that differed in binding to heparin showed that
lower binding was associated with higher viremia and usually
with greater virulence in newborn CD-1 mice (Byrnes and
Griffin, 2000). However, for some viruses, higher viremia did
not result in increased mortality. Recombinant viruses R157H
and K159E formed large plaques under agar (2.5 and 2.8 mm,
respectively; Toto 1101:1.3 mm), eluted from heparin-
Sepharose at similar NaCl concentrations (289 and 261
mM; Toto 1101: 323 mM) and had similar peak viremia
titers (7.7 and 7.5 log10 pfu; Toto 1101: 5.9 log10 pfu), butwith K157H and K159E. Two-day-old CD-1 or BALB/c mice were inoculated
e/group). CD-1 mice were more susceptible than BALB/c mice (P < 0.001), and
Kaplan–Meier analysis; BALB/c, P = 0.05, Chi square).
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shows 50% binding to HS-expressing cells, similar to that of
Toto 1101 (60%), while K159E shows minimal (20%)
binding similar to the 15–20% binding of all these viruses
to CHO cells lacking HS. R157H caused the death of 100%
of 2-day-old CD-1 mice, while K159E and Toto 1101 caused
30% mortality. For the current study, the virulence of R157H
and K159E was further characterized after subcutaneous
inoculation of 2 (Fig. 1A), 7- and 14-day-old CD-1 mice.
In 2-day-old CD-1 mice, infection with R157H caused 100%
mortality with a mean day of death (MDOD) of 5.82, while
infection with K159E caused 60% mortality with a MDOD of
7.0 (P = 0.0083). All 7- and 14-day-old mice survived
infection with both viruses.
Strains of mice differ in susceptibility as adults to fatal
infection with NSV, a neurovirulent strain of SINV with
BALB/c mice least susceptible (Thach et al., 2000; Tucker
et al., 1996). Differences in susceptibility in newborn mice
have not been studied, and most studies have used CD-1 mice.
To determine whether newborn BALB/c mice differ from
newborn CD-1 mice in susceptibility to SINV infection, 2-day-
old BALB/c mice were infected subcutaneously with R157H
and K159E. R157H caused 25% mortality (MDOD = 7.5),
while K159E caused no mortality (Fig. 1B) (P = 0.05).
Mortality was lower for both viruses than that observed in CD-
1 mice of the same age (P < 0.001), suggesting that previously
described genetic differences in murine susceptibility toFig. 2. Replication of R157H and K159E in CD-1 and BALB/c mice after subcuta
infected subcutaneously in the right hind foot with 1000 pfu of R157H and K159E. P
and brains (C, F) of 2–3 mice. *P < 0.05, Student’s t test.neurovirulent SINV infection in weanling mice are also
manifested in newborn mice.
Virus replication after subcutaneous inoculation
To determine whether differences in mortality between
R157H and K159E in 2-day-old CD-1 and BALB/c mice
reflected differences in virus replication at the site of
inoculation, in height or duration of viremia or virus entry
and replication in the CNS, tissues were collected at various
times after subcutaneous infection and assayed for infectious
virus (Fig. 2). For CD-1 mice, both viruses replicated similarly
at the site of inoculation in the foot (Fig. 2A) and produced
similar levels and duration of virus in the blood (Fig. 2B).
However, levels of viral replication in the brains were different,
with the R157H-infected mice having higher levels of virus
than K159E-infected mice at 2 (P = 0.07) and 3 (P = 0.05) days
after infection (Fig. 2C).
For BALB/c mice, levels of virus replication at the site of
inoculation in the foot and of virus in the blood produced by
R157H and K159E were also similar. Compared to CD-1 mice,
the maximum titers reached on day 1 were similar in foot
(Fig. 2D) and blood (Fig. 2E), but virus was cleared more
rapidly from both sites. Brain virus titers for R157H were
consistently higher than K159E (Fig. 2F), but titers for both
viruses were lower than those observed in the brains of CD-1
mice (Fig. 2C).neous inoculation. Two-day-old CD-1 (A–C) and BALB/c (D–F) mice were
oints represent the geometric means of the titers of the feet (A, D), blood (B, E),
Fig. 3. Levels of IFN and TNF-a in the brains of CD-1 mice infected with R157H and K159E. Brains from 2-day-old CD-1 mice infected subcutaneously with 1000
pfu R157H and K159E were assayed for levels of biologically active IFN by protection of L929 cells from infection with vesicular stomatitis virus and for TNF-a by
enzyme immunoassay. Bars indicate standard error. There were no significant differences in the levels of either cytokine.
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It has been suggested that SINV-induced death in neonatal
mice is due to a systemic inflammatory response syndrome,
rather than CNS infection (Klimstra et al., 1999; Trgovcich
et al., 1997). To determine if differential induction of cytokines
may be contributing to R157H-induced death of CD-1 mice,
levels of IFN and TNF-a were measured (Fig. 3). Levels of
these cytokines in the brains of mice infected with R157H or
K159E did not differ from one another.
Mortality and virus replication after intracerebral inoculation
To determine if the differences in virus replication in the
brain were due to differences in ability of R157H and K159E to
enter the CNS or to differential replication after entry, CD-1
mice were infected by intracerebral inoculation to bypass the
need for entry (Fig. 4). Both viruses caused 100% mortality;
however, there was a large difference in the time to death
between the viruses (Fig. 4A). All R157H-infected mice wereFig. 4. Mortality and replication of R157H and K159E in CD-1 mice after intrace
1000 pfu of recombinant viruses R157H and K159E. (A) Mortality. (B) Virus replica
from 2–3 mice. *P < 0.05, Student’s t test.dead by 4 days after infection (MDOD = 2), while K159E-
infected mice did not begin to die until day 6 (MDOD = 8.18,
P < 0.0001). R157H replicated more rapidly than K159E in the
CNS with higher brain titers at 6, 24, and 48 h after infection
(Fig. 4B). However, by day 4, virus production in K159E-
infected mice was equal to that of the R157H-infected mice.
All 1- and 2-week-old CD-1 mice infected intracerebrally with
R157H or K159E survived infection.
Replication in tissue culture cells
To determine whether the in vivo differences in replication
of R157H and K159E in the neurons of infected mice could be
reproduced in vitro, replication was assessed in BHK cells and
in undifferentiated and differentiated CSM 14.1 neuronal cells
and compared to Toto1101 (Fig. 5). All viruses replicated more
rapidly and to higher titer in BHK cells than in either
undifferentiated or differentiated CSM 14.1 neuronal cells.
K159E replicated to lower titer in BHK cells than Toto 1101 or
R157H (Fig. 5A), while R157H replicated better in undiffer-rebral inoculation. Two-day-old CD-1 mice were infected intracerebrally with
tion in the brain. Points represent the geometric means of the titers of the brains
Fig. 5. Replication of Toto1101, R157H, and K159E in tissue culture cells. BHK cells, undifferentiated and 3-week-differentiated CSM 14.1 cells were infected with
Toto1101, R157H, and K159E at a multiplicity of 1, and virus production was assessed by plaque formation in BHK cells. Points represent the geometric means of
triplicate samples T the standard error of the mean. ***P < 0.001; ****P < 0.0001, ANOVA.
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in differentiated CSM 14.1 cells (Fig. 5C).
Discussion
Amino acid alterations in the surface glycoproteins of
alphaviruses modulate neurovirulence (Davis et al., 1986;
Lustig et al., 1988; Tucker et al., 1993, 1996). One determinant
of virulence that is affected by amino acid changes in E2 is
binding to HS (Byrnes and Griffin, 2000; Klimstra et al.,
1998). One mechanism for the effect of HS binding on
virulence is a more rapid clearance of virus from the blood
after peripheral inoculation and a presumed decreased oppor-
tunity for entry into the CNS for viruses that bind HS well.
Here, we show, using recombinant viruses, that higher levels of
virus in blood were not sufficient for increased virulence, and
that the differences seen in replication in the CNS were not
predicted by binding to heparin. Virulence of R157H was
determined by an improved ability to replicate in the CNS of
newborn mice. This property was reflected in improved
replication in undifferentiated CSM 14.1 neuronal cells.
Furthermore, the genetic background of the mouse affected
outcome from SINV infection even in newborn mice.
The distinct effects of viremia and HS binding on neuro-
virulence suggest that the two parameters are separable. Entry
of alphaviruses into the CNS has been assumed to be through
infection of endothelial cells (Fazakerley, 2002; Johnson,
1965; Johnson, 1966), but there is also evidence for entry
through axonal transport by nerves innervating either a
peripheral site of replication or the olfactory mucosa (Charles
et al., 1995; Cook and Griffin, 2003). Both the endothelial cell
and olfactory routes of entry require spread to those sites
through the blood, and it is reasonable to assume that the
amount of virus in the blood and length of time it circulates
will influence the likelihood of infecting these sites and gaining
entry into the CNS. The level of viremia is determined both by
the amount of virus released into the blood and the rapidity
with which it is removed. Binding to HS increases the rate of
clearance of virus from the blood by the liver, an organ rich inthis glycosaminoglycan (Byrnes and Griffin, 2000). As with
SINV, laboratory strains of VEEV that bind HS well are
attenuated (Bernard et al., 2000). However, naturally occurring
equine-virulent epizootic strains of VEEV are often small
plaque and have an increase in positively charged amino acids
in E2 (Brault et al., 2002). R157H and K159E had similar
levels of replication at the initial site of inoculation and similar
viremia profiles, so replication in the periphery and clearance
from the blood did not account for differences in virulence.
Studies of other neurovirulent viruses have also shown that
level and duration of viremia do not always predict virulence
for neurotropic viruses (Jahrling et al., 1977; Monath et al.,
1983). These data suggest that other properties of the virus are
important for neurovirulence and could affect entry or
replication in neurons.
Entry into the CNS from the blood will require virus binding
either to brain endothelial cells or peripheral processes of
neurons. For human immunodeficiency virus, there is in vitro
evidence that HS improves efficiency of binding to brain
microvascular endothelial cells, and this is postulated to
facilitate entry of this virus into the CNS (Banks et al., 2004;
Bobardt et al., 2004). In SINV(Peleg), substitution of lysine at
E2-190 for methionine is associated with neuroinvasiveness
(Dubuisson et al., 1997). A basic amino acid in this region of
E2 may facilitate binding to HS and suggest a link to
neuroinvasion. In contrast, for Murray Valley encephalitis
virus increased binding to HS is associated with loss of
neuroinvasiveness (Lee and Lobigs, 2000).
Our studies suggest that R157H entered the CNS similarly
to K159E, but replicated better in neurons once within the
CNS. Although R157H and K159E bind similarly to heparin-
Sepharose and to cells lacking HS, R157H retains the ability to
bind preferentially to cells that express HS (Byrnes and Griffin,
2000). This fact probably accounts for the preferential
replication of R157H and Toto 1101 in BHK cells compared
to K159E. However, in undifferentiated CSM neuronal cells,
R157H replicated better than either Toto 1101 or K159E.
Increased replication by R157H in undifferentiated CSM
14.1 cells and in the brains of newborn mice is probably
J.S. Bear et al. / Virology 347 (2006) 183–190188linked to properties of E2 conferred by the change from
arginine to histidine at E2 157 distinct from those conferred by
a change from lysine to glutamate at E2 159 and not reflected
in binding to heparin-Sepharose. Differences in binding to
various forms of this sulfated glycosaminoglycan may be
relevant to an increased ability to infect and replicate in
neurons. Interestingly, selection for decreased HS binding by
Theilers murine encephalomyelitis virus results in loss of
neurovirulence for mice and alters the types of neurons infected
(Reddi et al., 2004).
The viruses used in this study were derivatives of Toto1101,
a strain of SINV that can cause disease only in very young
mice (Lustig et al., 1988; Sherman and Griffin, 1990).
Susceptibility of mice to these viruses decreased within a few
days after birth so that CD-1 mice with 100% mortality at
2 days of age were completely resistant to fatal encephalitis at
7 days of age after either subcutaneous or intracerebral
inoculation of virus. Interestingly, this was reflected in the
relative ability of the viruses to replicate in undifferentiated and
differentiated CSM 14.1 cells. The basis for age-dependent
susceptibility of the CNS to alphavirus infection is not known.
Like undifferentiated CSM14.1 cells, neurons of newborn mice
are still proliferating and are susceptible to apoptotic cell
death, while neurons in mature animals and differentiated CSM
14.1 cells are not (Burdeinick-Kerr and Griffin, 2005; Havert et
al., 2000; Lewis et al., 1996; Vernon and Griffin, 2005). Virus
grows to higher titer in immature than mature neurons (Johnson
et al., 1972), and this replication advantage was also observed
in undifferentiated CSM 14.1 cells compared to differentiated
CSM 14.1 cells.
The differences between CD-1 and BALB/c mice were
unexpected. Adult BALB/c mice are relatively resistant to fatal
encephalomyelitis after infection with VEEV and a neuroa-
dapted strain of SINV (NSV) (Steele et al., 1998; Thach et al.,
2000). For NSV, this resistance is associated with restricted
virus replication early after CNS infection. The gene respon-
sible maps to chromosome 2 (Thach et al., 2001) and the
current studies indicate that this trait restricts virus replication
in young, as well as mature, mice. These data further suggest
that the restriction to virus replication identified in adult
BALB/cBy mice is not due to differences in the adaptive
immune response to virus infection.
Materials and methods
Cells
BHK-21 and L-929 cells were grown in Dulbecco’s
modified Eagle medium (DMEM; Gibco BRL, Gaithersburg,
MD) containing 10% fetal bovine serum (FBS; Sigma Corp.,
St. Louis, MO), gentamicin and glutamine. CSM 14.1 cells, a
line of rat mesencephalon cells immortalized by a temperature-
sensitive SV40 large T antigen (gift from Dale Bredeson, Buck
Institute, Novato, CA) (Zhong et al., 1993), were grown at
31 -C in DMEM with 10% FBS. For differentiation, CSM
14.1 cells were changed to DMEM/1% FBS and shifted to
39 -C, the nonpermissive temperature. Under these conditions,cell division ceases, and the cells develop a neuron-like
morphology and physiology. CSM 14.1 cells were differenti-
ated for 3 weeks at which time they are relatively resistant to
the cytopathic effects of SINV (Burdeinick-Kerr and Griffin,
2005; Vernon and Griffin, 2005).
Viruses and virus assays
Construction of recombinant viruses TotoR157H and
TotoK159E has been previously described (Byrnes and Griffin,
2000). Briefly, mutations were introduced into pToto1101 (gift
from Charles Rice, Rockefeller University) (Rice et al., 1987)
by site-directed mutagenesis to change the positively charged
amino acids arginine (R) at E2-157 and lysine (K) at E2-159 to
histidine (H) and glutamic acid (E) respectively. These amino
acids were selected for substitution based on the mutations
found in naturally arising large-plaque variants associated with
prolonged viremia in mice (Byrnes and Griffin, 2000). Virus
stocks were produced as previously described (Byrnes and
Griffin, 2000) by transfecting RNA transcribed from cDNA
into pgsA HS-deficient Chinese hamster ovary (CHO) cells,
collecting supernatant fluid and assaying infectious virus by
plaque formation on BHK-21 cells. Stock virus was stored in
aliquots at 80 -C.
For one-step growth curves, virus was diluted in DMEM/
1% FBS, and cells were infected for 1 h at a multiplicity of 1,
washed 3 times and 1 ml DMEM/1% FBS added. At each time
point, 200 Al of media was removed and replaced with fresh
media. For virus titration, serial dilutions of supernatant fluids,
tissue homogenates, or blood samples were inoculated onto
monolayers of BHK cells, overlaid with a 1:1 mixture of
modified Eagle medium without phenol red supplemented with
2% FBS and 0.6% bactoAgar. After 48 h, plaques were stained
with neutral red and counted.
Mice
Studies used litters of 2-day-old CD-1 and BALB/c mice
and 1- and 2-week-old CD-1 mice (Charles River Laboratories,
Wilmington, MA). Mice were inoculated either intracerebrally
in the right cerebral hemisphere or subcutaneously in the right
hind foot with 1000 plaque-forming units (pfu) of virus diluted
in Hanks balanced salt solution. For mortality studies, infected
mice were observed daily for 14–21 days. For analysis of virus
replication in tissues, mice were anesthetized and brain, blood,
and/or hind foot samples taken. Tissues were individually
weighed, frozen, and homogenized in phosphate-buffered
saline, pH 7.4 (PBS) for use in assays of virus, interferon
(IFN), and tumor necrosis factor (TNF)-a. All animal studies
were performed according to protocols approved by the Johns
Hopkins University Animal Care and Use Committee.
TNF-a and IFN assays
Samples consisted of clarified brain homogenates (40%w/v).
TNF-a was measured by enzyme immunoassay (OptEIA kit,
PharMingen) according to the manufacturer’s protocol. For
J.S. Bear et al. / Virology 347 (2006) 183–190 189biological assay of IFN in brain, infectious SINV was
inactivated by treatment of homogenates with 0.1 N HCl
to pH 2 overnight at 4 -C. The homogenates were then
neutralized with 0.1 N NaOH, serially diluted, and added to
L929 cells in 96-well plates along with known amounts of
murine interferon a (Sigma). The plates were incubated
overnight, washed, and then challenged with 100 TCID50 of
vesicular stomatitis virus. After 48 h, the plates were stained
with crystal violet. The concentration of IFN in the brain
samples was determined by comparison of protection from
cytopathic effect with the IFN control.
Statistical analysis
Statistical analysis used Statview 5.0 software (SAS, Cary,
NC). Differences in mortality were assessed using the Kaplan–
Meier method with the Mantel–Cox log rank test for
significance. Chi-square test was used for comparisons when
one of the groups had no mortality. Viral titers, IFN levels, and
TNF-a levels in mice were compared using Student’s t test.
Viral titers in cell culture were compared using ANOVA.
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